Synergistic Herbal Ophthalmic Formulation for Glaucoma IOP Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for glaucoma, primarily relying on synthetic drugs, are toxic, expensive, and require frequent administration, leading to poor patient compliance and adverse reactions, while herbal alternatives are underutilized for their ocular hypotensive effects.

Innovation Solution

A synergistic herbal composition comprising extracts from Ocimum species, Curcuma species, and Solanum nigrum, optionally with Areca catechu, formulated into pharmaceutically acceptable ophthalmic dosage forms such as eye drops, ointments, or gels, to lower intraocular pressure effectively.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If synthetic drugs are used to lower intraocular pressure, then IOP reduction effect is achieved, but toxicity and adverse reactions increase

Engineering Contradiction:
ImproveIOP reduction effectVSAvoidtoxicity and adverse reactions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical composition parameters by replacing synthetic compounds with herbal extracts (Ocimum species, Curcuma species, Solanum nigrum, Areca catechu) that produce IOP reduction through different biochemical pathways, thereby maintaining therapeutic efficacy while reducing toxicity and adverse reactions associated with conventional synthetic glaucoma medications

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent combines multiple herbal extracts in a composite formulation where each herb contributes different bioactive compounds that work synergistically to lower IOP through multiple mechanisms (decreasing aqueous formation, increasing outflow), thereby achieving reliable IOP control while minimizing harmful effects that occur with single synthetic agents

Inventive Principle:
Principle #40Composite materials

2Reliability

If synthetic drugs are administered frequently to control IOP, then IOP control is maintained, but patient compliance deteriorates

Engineering Contradiction:
ImproveIOP controlVSAvoidpatient compliance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The herbal formulation is designed to provide sustained IOP control with longer duration of action compared to conventional synthetic drugs, reducing the frequency of administration required and thereby improving patient compliance while maintaining reliable IOP control throughout the treatment period

Inventive Principle:
Principle #10Preliminary action

3Reliability

If synthetic drugs are used for glaucoma treatment, then IOP lowering effect is achieved, but treatment cost increases

Engineering Contradiction:
ImproveIOP lowering effectVSAvoidtreatment cost
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent employs herbal extracts that can be sourced from renewable plant materials, making the formulation more cost-effective compared to synthetic drugs that require complex chemical synthesis. The use of naturally occurring herbs (Ocimum species, Curcuma species, Solanum nigrum, Areca catechu) reduces manufacturing and treatment costs while maintaining IOP lowering efficacy

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Data Source

PatentUS8679557B2Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma
Publication Date: 2014.03.25 SENTISS PHARMA

AI summary

The present invention relates to a synergistic herbal composition for lowering the intra ocular pressure in different types of glaucoma and process for the preparation of the same in pharmaceutically acceptable dosage forms.